Statement doctors from the National Institute of Allergy and Infectious Diseases.

Antiviral treatment can lead to drug-resistant H1N1 virus: NIAID Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, statement doctors from the National Institute of Allergy and Infectious Diseases , section of the National Institutes of Health. Doctors who deal with prolonged influenza infection should be aware that a good short course of antiviral treatment may lead to drug-resistant virus, state the authors, and clinicians should think about this possibility because they develop preliminary treatment approaches for their patients who have impaired immune function. Both sufferers in the new report developed level of resistance to the main element influenza drug oseltamivir , and one also demonstrated clinical resistance to another antiviral agent, in experimental testing now, intravenous peramivir, take note senior authors Matthew J http://www.sildenafilschweiz.com/ .

viagra kaufen legal

An antigen-capture enzyme-connected immunosorbant assay test for Ebola offers the chance for diagnosis within the initial few days after symptoms start. Related StoriesReady-to-make use of tagged cDNA clonesOrganoid Biobank for predicting cancer tumor individual response to drugsGMP quality cell cryopreservation mediaEbola, also referred to as Ebola hemorrhagic fever, is a disease that occurs in outbreaks in the tropical regions of Sub-Saharan Africa typically. The 1st known outbreak occurred in 1976 and the biggest outbreak to date is the ongoing 2014 West Africa Ebola virus outbreak-which has effects on Guinea, Sierra Leone, Nigeria and Liberia.

Other entries from category "doctor":

Random entries